<--- Back to Details
First PageDocument Content
Pharmacology / Fixed dose combination / Organofluorides / Gilead Sciences / Post-exposure prophylaxis / Sexually transmitted diseases and infections / Tenofovir/emtricitabine / Lamivudine / Lopinavir/ritonavir / Medicine / Chemistry / HIV/AIDS
Date: 2014-01-08 01:50:15
Pharmacology
Fixed dose combination
Organofluorides
Gilead Sciences
Post-exposure prophylaxis
Sexually transmitted diseases and infections
Tenofovir/emtricitabine
Lamivudine
Lopinavir/ritonavir
Medicine
Chemistry
HIV/AIDS

PMH NPEP protocol dec 2012

Add to Reading List

Source URL: kidshealthwa.com

Download Document from Source Website

File Size: 164,23 KB

Share Document on Facebook

Similar Documents

AIDS InfoNetwww.aidsinfonet.org Fact Sheet Number 478 Biktarvy (bictegravir + emtricitabine + tenofovir alafenamide)

DocID: 1ucKl - View Document

Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection

DocID: 1rPaA - View Document

PrEPARING FOR THE END OF HIV? How to access PrEP in Contra Costa County… For Insured Folks: Private Medical Provider-Most health insurance companies cover Truvada (emtricitabine and tenofovir disoproxil fumarate, the m

DocID: 1rAVd - View Document

Medicine / Pre-exposure prophylaxis / Prevention of HIV/AIDS / Tenofovir/emtricitabine / Callen-Lorde Community Health Center / Health / IPrEx

Trans and Gender Non-Conforming (TGNC) Folks and PrEP: WHAT WE SHOULD KNOW

DocID: 1reG7 - View Document

Medicine / Health / Gilead Sciences / Pre-exposure prophylaxis / Tenofovir/emtricitabine / Medical prescription / Emtricitabine / Tenofovir disoproxil / Health Insurance Portability and Accountability Act / Personal health record

Patient Name:________________________________________ Date of Birth:__________________ Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

DocID: 1qMRc - View Document